Abstract
Neurodegenerative diseases (NDs) are progressive disorders that cause the degeneration of neurons. Mitochondrial dysfunction is a common symptom in NDs and plays a crucial role in neuronal loss. Mitochondrial abnormalities can be observed in the early stages of NDs and evolve throughout disease progression. Visualizing mitochondrial abnormalities can help understand ND progression and develop new therapeutic strategies. Fluorescence microscopy is a powerful tool for dynamically imaging mitochondria due to its high sensitivity and spatiotemporal resolution. This review discusses the relationship between mitochondrial dysfunction and ND progression, potential biomarkers for imaging dysfunctional mitochondria, advances in fluorescence microscopy for detecting organelles, the performance of fluorescence probes in visualizing ND-associated mitochondria, and the challenges and opportunities for developing new generations of fluorescence imaging platforms for monitoring mitochondria in NDs.
Author supplied keywords
Cite
CITATION STYLE
Wang, Y., Wang, P., & Li, C. (2023, June 1). Fluorescence microscopic platforms imaging mitochondrial abnormalities in neurodegenerative diseases. Advanced Drug Delivery Reviews. Elsevier B.V. https://doi.org/10.1016/j.addr.2023.114841
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.